CROSS COUNTRY HEALTHCARE INC (CCRN) Stock Fundamental Analysis
USA - NASDAQ:CCRN - US2274831047 - Common Stock
10.84 USD
-0.7 (-6.07%)
11.05 USD
+0.21 (+1.94%)
Overall CCRN gets a fundamental rating of 5 out of 10. We evaluated CCRN against 100 industry peers in the Health Care Providers & Services industry. While CCRN has a great health rating, its profitability is only average at the moment. CCRN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CCRN was profitable.
In the past year CCRN had a positive cash flow from operations.
In multiple years CCRN reported negative net income over the last 5 years.
Of the past 5 years CCRN 4 years had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CCRN (-1.51%) is comparable to the rest of the industry.
With a Return On Equity value of -2.02%, CCRN perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
CCRN's Return On Invested Capital of 1.44% is in line compared to the rest of the industry. CCRN outperforms 41.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCRN is significantly above the industry average of 9.38%.
The last Return On Invested Capital (1.44%) for CCRN is well below the 3 year average (15.05%), which needs to be investigated, but indicates that CCRN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROIC | 1.44% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
1.3 Margins
CCRN has a Operating Margin (0.78%) which is comparable to the rest of the industry.
CCRN's Operating Margin has declined in the last couple of years.
CCRN has a Gross Margin (20.19%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CCRN has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% |
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCRN is still creating some value.
The number of shares outstanding for CCRN has been reduced compared to 1 year ago.
CCRN has less shares outstanding than it did 5 years ago.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 4.71 indicates that CCRN is not in any danger for bankruptcy at the moment.
CCRN's Altman-Z score of 4.71 is amongst the best of the industry. CCRN outperforms 81.00% of its industry peers.
CCRN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.71 |
ROIC/WACC0.16
WACC9.04%
2.3 Liquidity
A Current Ratio of 3.21 indicates that CCRN has no problem at all paying its short term obligations.
CCRN's Current ratio of 3.21 is amongst the best of the industry. CCRN outperforms 86.00% of its industry peers.
CCRN has a Quick Ratio of 3.21. This indicates that CCRN is financially healthy and has no problem in meeting its short term obligations.
CCRN's Quick ratio of 3.21 is amongst the best of the industry. CCRN outperforms 87.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 |
3. Growth
3.1 Past
CCRN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -78.35%.
CCRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.57% yearly.
CCRN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.30%.
Measured over the past years, CCRN shows a quite strong growth in Revenue. The Revenue has been growing by 10.33% on average per year.
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
3.2 Future
The Earnings Per Share is expected to decrease by -16.16% on average over the next years. This is quite bad
CCRN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.63% yearly.
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 51.62, which means the current valuation is very expensive for CCRN.
The rest of the industry has a similar Price/Earnings ratio as CCRN.
The average S&P500 Price/Earnings ratio is at 25.07. CCRN is valued rather expensively when compared to this.
A Price/Forward Earnings ratio of 41.27 indicates a quite expensive valuation of CCRN.
CCRN's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 34.08. CCRN is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.62 | ||
| Fwd PE | 41.27 |
4.2 Price Multiples
CCRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CCRN is cheaper than 72.00% of the companies in the same industry.
85.00% of the companies in the same industry are more expensive than CCRN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.42 | ||
| EV/EBITDA | 10.12 |
4.3 Compensation for Growth
CCRN's earnings are expected to decrease with -16.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.1
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
5. Dividend
5.1 Amount
No dividends for CCRN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
10.84
-0.7 (-6.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.83%
Inst Owner Change-0.49%
Ins Owners5.37%
Ins Owner Change-0.64%
Market Cap355.12M
Revenue(TTM)1.19B
Net Income(TTM)-8.35M
Analysts52.31
Price Target18.44 (70.11%)
Short Float %8.05%
Short Ratio6.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-56.4%
Min EPS beat(2)-118.38%
Max EPS beat(2)5.59%
EPS beat(4)2
Avg EPS beat(4)-39.17%
Min EPS beat(4)-118.38%
Max EPS beat(4)22.23%
EPS beat(8)4
Avg EPS beat(8)-22%
EPS beat(12)8
Avg EPS beat(12)-10.41%
EPS beat(16)12
Avg EPS beat(16)-0.77%
Revenue beat(2)0
Avg Revenue beat(2)-6.65%
Min Revenue beat(2)-7.46%
Max Revenue beat(2)-5.84%
Revenue beat(4)0
Avg Revenue beat(4)-3.61%
Min Revenue beat(4)-7.46%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.89%
Revenue beat(16)7
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-42.1%
EPS NY rev (1m)0%
EPS NY rev (3m)-54.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.06%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 51.62 | ||
| Fwd PE | 41.27 | ||
| P/S | 0.3 | ||
| P/FCF | 10.42 | ||
| P/OCF | 8.54 | ||
| P/B | 0.86 | ||
| P/tB | 1.48 | ||
| EV/EBITDA | 10.12 |
EPS(TTM)0.21
EY1.94%
EPS(NY)0.26
Fwd EY2.42%
FCF(TTM)1.04
FCFY9.6%
OCF(TTM)1.27
OCFY11.71%
SpS36.4
BVpS12.58
TBVpS7.31
PEG (NY)N/A
PEG (5Y)2.1
Graham Number7.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.51% | ||
| ROE | -2.02% | ||
| ROCE | 2.04% | ||
| ROIC | 1.44% | ||
| ROICexc | 1.75% | ||
| ROICexgc | 3.24% | ||
| OM | 0.78% | ||
| PM (TTM) | N/A | ||
| GM | 20.19% | ||
| FCFM | 2.86% |
ROA(3y)9.37%
ROA(5y)8.5%
ROE(3y)17.7%
ROE(5y)17.81%
ROIC(3y)15.05%
ROIC(5y)13.58%
ROICexc(3y)15.28%
ROICexc(5y)13.73%
ROICexgc(3y)22.9%
ROICexgc(5y)20.79%
ROCE(3y)21.31%
ROCE(5y)19.23%
ROICexgc growth 3Y-75.41%
ROICexgc growth 5Y-32.32%
ROICexc growth 3Y-77.25%
ROICexc growth 5Y-30.83%
OM growth 3Y-77.97%
OM growth 5Y-33.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y-3.83%
F-Score5
Asset Turnover2.15
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 42.39% | ||
| Cap/Sales | 0.63% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 153.74% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.21 | ||
| Quick Ratio | 3.21 | ||
| Altman-Z | 4.71 |
F-Score5
WACC9.04%
ROIC/WACC0.16
Cap/Depr(3y)64.63%
Cap/Depr(5y)60.57%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-78.35%
EPS 3Y-47.22%
EPS 5Y24.57%
EPS Q2Q%-110%
EPS Next Y-68.27%
EPS Next 2Y-23.6%
EPS Next 3Y-16.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.3%
Revenue growth 3Y-7.11%
Revenue growth 5Y10.33%
Sales Q2Q%-19.34%
Revenue Next Year-16.68%
Revenue Next 2Y-8.76%
Revenue Next 3Y-5.63%
Revenue Next 5YN/A
EBIT growth 1Y-69.02%
EBIT growth 3Y-79.54%
EBIT growth 5Y-27.01%
EBIT Next Year540.8%
EBIT Next 3Y89.71%
EBIT Next 5YN/A
FCF growth 1Y-88.57%
FCF growth 3YN/A
FCF growth 5Y112.02%
OCF growth 1Y-86.63%
OCF growth 3YN/A
OCF growth 5Y85.29%
CROSS COUNTRY HEALTHCARE INC / CCRN FAQ
What is the ChartMill fundamental rating of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CCRN.
Can you provide the valuation status for CROSS COUNTRY HEALTHCARE INC?
ChartMill assigns a valuation rating of 3 / 10 to CROSS COUNTRY HEALTHCARE INC (CCRN). This can be considered as Overvalued.
Can you provide the profitability details for CROSS COUNTRY HEALTHCARE INC?
CROSS COUNTRY HEALTHCARE INC (CCRN) has a profitability rating of 4 / 10.
What is the financial health of CROSS COUNTRY HEALTHCARE INC (CCRN) stock?
The financial health rating of CROSS COUNTRY HEALTHCARE INC (CCRN) is 10 / 10.